Rigorous research and developments on other BMP applications have become critical differentiating strategy. However, Rising Traumatic Injury Caseloads Remain Pivotal to Growth.
In its latest market analysis, ResearchMoz has revealed that the global
market revenue of bone
morphogenetic proteins will clock nearly US$ 704 Mn by 2027. ResearchMoz
uncovers the global bone morphogenetic proteins market in detail in its report
that includes the drivers, restraints, opportunities, threats and competitive
topography during the forecast period.
Players Uncovering
Potential Avenues in Dentistry
The utilization of bone morphogenetic proteins is not only concentrated
on osteogenic regeneration. Instead, BMP producers, along with medical
researchers, are conducting extensive studies in other areas, including
periodontal regeneration and tooth conservation procedures. In dentistry, BMP-2
is seeing huge demand uptick in several medical procedures, including sinus
lift augmentation, alveolar bone regeneration, and dental implants. Such
discoveries are influencing market players to devise innovative biomaterials
for BMP delivery in these potential avenues.
BMPs to Act as
Possible Bridge between Bone Metabolisms with Obesity
Riding the wave of meticulous Research and Development, players in bone
morphogenetic proteins market are striving to determine relationship
between bone metabolism and obesity as well as glucose metabolism. Studies have
highlighted impact of bone morphogenetic proteins – BMP9, BMP7, BMP6, BMP4, and
BMP2 – on pathophysiological process of glucose metabolism and obesity beyond
bone metabolism. Furthermore, holistic understanding of impacts of bone
morphogenetic proteins could help market players better understand bone
metabolism in obesity and type-2 diabetes.
Analysts’ Views
The market is witnessing major impetus from increasing spinal injury
caseloads, especially in Gen X and geriatric cohorts, and conducive regulatory
environment. Moreover, bone morphogenetic proteins easily align with the
intensifying awareness and need for minimally-invasive treatments. In order to
sustain their revenue growth, players are joining hands with healthcare
researchers to tap into potential applications of bone morphogenetic proteins.
“During 2020-2021, about 470, 000 people suffered work-related
musculoskeletal disorders. Of those caseloads, around 40% patients endured
spinal injuries. Bone morphogenetic proteins promote formation and repairment
of affected bones and cartilages. This reduces dependence on spinal screws and
rods and, thus, the painful procedure of invasive surgeries,” elucidates
ResearchMoz
APAC BMP Market to
Grow at Breakneck Speed
The report underscores fast-paced growth of bone morphogenetic proteins
market in Asia Pacific (APAC). Increasing healthcare spending, especially in
China, India, and Singapore, and rising prominence of recombinant human
bone morphogenetic proteins (rhBMP) are critical growth engines.
Besides, cost-effective healthcare services, superior hospitality, and
leading-edge medical technologies (MedTech) have bolstered medical tourism in
APAC. Thailand, Malaysia, and India are leading the pack in this theme.
Competitive
Landscape
ResearchMOZ underscores the competitive gradient of the bone
morphogenetic proteins market which would enable the new entrants to extract
factual information regarding the strategies adopting by the leading players in
order to dive deeper into the uncharted regions and grab their positions.
The leading players of the bone morphogenetic proteins market are
- ProSpec
- DePuy
Synthes
- Ember
Therapeutics Inc
- Sigma-Aldrich
Corporation
- R&D
Systems
- Cellumed
Co. Ltd.
Download FREE
Sample Report (Get Full Insights in PDF) @ https://www.researchmoz.us/request-free-sample/?reportid=1497
No comments:
Post a Comment